Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Person
|
| gptkbp:advocacy |
Patient access to therapies
|
| gptkbp:affiliation |
gptkb:Spark_Therapeutics
|
| gptkbp:almaMater |
gptkb:University_of_Pennsylvania
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:birthPlace |
gptkb:United_States
|
| gptkbp:businessModel |
Scaling_operations_at_Spark_Therapeutics
|
| gptkbp:children |
Not publicly disclosed
|
| gptkbp:collaborations |
Research institutions
Global health initiatives |
| gptkbp:communityEngagement |
Support for local health initiatives
|
| gptkbp:communityPartnerships |
Collaborating with research organizations
|
| gptkbp:contribution |
Development of Luxturna
|
| gptkbp:education |
gptkb:University_of_Pennsylvania
|
| gptkbp:field |
Biotechnology
|
| gptkbp:founder |
gptkb:Spark_Therapeutics
|
| gptkbp:futurePlans |
Expand gene therapy portfolio
|
| gptkbp:goal |
Cure genetic diseases
|
| gptkbp:healthcare |
Promoting access to therapies
|
| gptkbp:homeGround |
Pharmaceutical and biotech sectors
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jeffrey D. Marrazzo
|
| gptkbp:impact |
Advancements in gene therapy
|
| gptkbp:influence |
Biotechnology policies
|
| gptkbp:influencedBy |
Biotechnology industry leaders
|
| gptkbp:innovation |
Driving technological advancements
|
| gptkbp:inspiration |
In the field of gene therapy
Personal experiences with genetic diseases |
| gptkbp:involved |
Clinical trials
|
| gptkbp:keyEvent |
Successful product launches
|
| gptkbp:knownFor |
Gene therapy innovations
Co-founder_of_Spark_Therapeutics |
| gptkbp:leadership |
CEO
Innovative and collaborative Mentoring future leaders Empowerment and teamwork Growth of Spark Therapeutics |
| gptkbp:localEconomy |
Advancing healthcare solutions
|
| gptkbp:marketingStrategy |
Focus on rare diseases
|
| gptkbp:mentor |
Emerging biotech leaders
|
| gptkbp:nationality |
American
|
| gptkbp:network |
Biotech_community
Biotech_executives |
| gptkbp:occupation |
Business executive
|
| gptkbp:partnerships |
Pharmaceutical companies
|
| gptkbp:philanthropy |
Support for genetic research
|
| gptkbp:positionHeld |
gptkb:CEO_of_Spark_Therapeutics
|
| gptkbp:publicAccess |
Improve lives through innovation
|
| gptkbp:publications |
Various scientific articles
|
| gptkbp:publicSpeaking |
Industry conferences
|
| gptkbp:research |
Investing in gene therapy research
|
| gptkbp:researchContribution |
Advancements in gene therapy technology
|
| gptkbp:researchFocus |
Rare genetic diseases
|
| gptkbp:residence |
gptkb:Philadelphia,_Pennsylvania
|
| gptkbp:spouse |
Not publicly disclosed
|
| gptkbp:strategicGoals |
Innovate in gene therapy
Pioneering gene therapy solutions Long-term_growth_of_Spark_Therapeutics |
| gptkbp:teamAchievements |
Fostering a collaborative culture
|
| gptkbp:vision |
Transforming genetic disease treatment
Transforming patient care through gene therapy |
| gptkbp:website |
sparktherapeutics.com
|
| gptkbp:yearsActive |
2013-present
|